News for SWK Holdings Corporation (SWKH)

U.S. stock futures were higher this morning, with the Dow futures gaining over 200 points on Tuesday. Shares of New Oriental Education & Technology Group Inc. ...

Shares of INNOVATE Corp. VATE rose sharply in today's pre-market trading. INNOVATE announced the FDA approval of MediBeacon’s TGFR System For accurate kidney...

SWK Holdings' baby bond is a compelling investment for income investors, with strong cash generation and stable investment yields. Explore more details here.

DALLAS, TX / ACCESSWIRE / January 6, 2025 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company ca

SWK Holdings updates on recent financial activities

Eton Pharmaceuticals acquires rare disease drug Increlex

SWK Holdings specializes in healthcare financing through term loans and royalty agreements. Learn more here about the bond from SWKH.

SWK Holdings Corporation Announces Financial Results for Second Quarter 2024

Relief Therapeutics Secures up to $11 Million from Royalty Sales

Operator: Good morning, everyone, and welcome to the SWK Holdings First Quarter 2024 Conference Call.

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and...